Timber Pharmaceuticals Inc (NYSE American:TMBR)
| 0.1255 Delayed Data As of 3:59pm ET |  -0.0039 / -3.01%Today’s Change | 0.09 Today|||52-Week Range 1.12 | -66.97% Year-to-Date |
Latest TMBR News | Press Releases
| AVEO Pharmaceuticals (AVEO) Reports Q2 Loss, Misses Revenue Estimates Aug 04 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 0.13 |
| Today’s open | 0.13 |
| Day’s range | 0.12 - 0.13 |
| Volume | 11,408,830 |
| Average volume (3 months) | 7,337,288 |
| Market cap | $18.1M |
Data as of 3:59pm ET, 08/16/2022
Growth & Valuation
| Earnings growth (last year) | +66.43% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -100.00% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| VBLTVascular Biogenics L... | -0.01 | -3.53% |
| YMTXYumanity Therapeutic... | +0.04 | +2.45% |
| CWBRCohBar Inc | -0.01 | -4.76% |
| PALIPalisade Bio Inc | -0.03 | -12.02% |
Data as of 3:59pm ET, 08/16/2022
Financials
| Next reporting date | November 16, 2022 |
| EPS forecast (this quarter) | -$0.05 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$9.7M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Basking Ridge, New Jersey |
Forecasts
